Please verify that you are a Healthcare Professional. Register for complete access to all the content!
Why smoking remains a critical obstacle to Helicob...
Helicobacter pylori (H. pylori) remains highly prevalent in Brazil, increasing the risk of gastritis, peptic ulcers, and gastric cancer. Although...
Experts issue consensus guidelines on GERD managem...
Gastroesophageal reflux disease (GERD) is highly prevalent during pregnancy, yet its evaluation and treatment have lacked uniform, locally releva...
1 min
Short-term nimesulide use demonstrates good tolera...
A clinical study evaluating the safety of nimesulide in patients with rheumatological complaints reports modest alterations in liver function par...
2 min
Seoul consensus releases 34 recommendations to sta...
Functional constipation continues to represent a common and heterogeneous gastrointestinal disorder with rising prevalence, variable symptom pres...
1 min
Rebamipide + tegoprazan shows superior healing of...
Managing gastric ulcers that develop after endoscopic submucosal dissection (ESD) remains a clinical challenge, with no universally accepted stan...
2 min
Effectiveness of PCAB vs. high-dose PPI in refract...
Gastroesophageal reflux disease (GERD) is a chronic ailment marked by the reflux of gastric contents into the esophagus, resulting in persistent...
6 min
Taking NSAIDs after 60? Study warns of increased G...
A large hospital-based study from Beijing has identified significant risk factors associated with nonsteroidal anti-inflammatory drug (NSAID)-ind...
2 min
Surgery reduces recurrence risk in adhesive small...
Adhesive small bowel obstruction (ASBO) remains one of the most frequent causes of hospitalization for intestinal obstruction, most often occurri...
1 min
Non-inferior healing and tolerability of tegopraza...
Tegoprazan, a next-generation potassium-competitive acid blocker (P-CAB), is designed for rapid acid suppression and sustained gastric pH control...
1 min
GERD cases surge globally, targeting younger adult...
A new analysis of Global Burden of Disease (GBD) 2021 data highlights a significant increase in gastroesophageal reflux disease (GERD) worldwide,...
1 min
Large screening study clarifies Barrett’s esophagus risk factors
Large-scale screening evidence indicates that Barrett’s esophagus risk is driven more by sex and smoking status than by H. pylori infection...
Clinical impact of feeding team involvement in pediatric eosinoph...
Multidisciplinary feeding interventions enhance symptom recovery in children with eosinophilic esophagitis, reinforcing the value of comprehensiv...
New research highlights 48-Hour treatment threshold in gallstone...
Patients with symptomatic gallstones face a rapidly rising risk of complex gallbladder surgery when treatment is postponed beyond the first 48 ho...
Omeprazole–domperidone combination delivers significant symptom r...
An omeprazole–domperidone combination provides substantial symptomatic relief in APD while supporting improved glycemic control in patients...
Eravacycline is a fully synthetic fluorocycline antibiotic structurally related to tetracyclines. Approved by the Food and Drug Administration on...
Management strategies for small bowel obstruction without prior s...
Most patients with small bowel obstruction without prior abdominal surgery are successfully managed with nonoperative treatment, reducing unneces...
Mediterranean low-FODMAP diet for non-constipated IBS: Clinical o...
In patients with non-constipated irritable bowel syndrome, a Mediterranean low-FODMAP diet provides greater and more sustained symptom relief, qu...
New prognostic model identifies key risk factors for incontinence...
A newly developed predictive model identifies mobility decline, reduced functional independence, and skin characteristics as major indicators of...
Persistent Belching in Functional Dyspepsia Successfully Treated...
Functional dyspepsia (FD) is a common gastrointestinal (GI) ailment that causes upper abdominal symptoms without structural disease. Chronic belc...
Exploring the causal link between menarche onset and risk of gall...
Earlier age at menarche increases the risk of gallstone disease, with liver function, lipid metabolism, and body fat acting as key mediators.
Clinical outcomes of RefluxStop for gastroesophageal reflux disea...
RefluxStop markedly reduces GERD-HRQL scores while maintaining a 95.5% patient satisfaction rate.
Fidaxomicin is a novel macrocyclic macrolide antibiotic and the first member of a new class of antimicrobial agents.
This website uses cookies to help us give you the best experience when you visit.
By using this website you consent to our use of cookies. For more information please review our cookie policy.